Stephen Parker

Stephen Parker

Fortuna: 184 194 $ al 31/08/2026

67 años
Health Technology
Finance
Commercial Services

Perfil

Dr. Stephen B. Parker is a Non-Executive Chairman at Biodexa Pharmaceuticals Plc, a Non-Executive Chairman at Drishti Discoveries Ltd., an Executive Chairman at Sareum Holdings Plc and a Partner at Celtic Pharma Management LP.
He is on the Board of Directors at Eternans Ltd., Sp2 Asset Management Ltd., Sareum Ltd. and Sp2 Consulting Ltd. Dr. Parker was previously employed as a Non-Executive Chairman by MGC Pharmaceuticals Ltd., a Chairman by Liverpool Chirochem Ltd., an Independent Non-Executive Director by Silence Therapeutics Plc, a Partner by Beehive Capital LLP, a Non-Executive Chairman by Physiomics Plc, a Principal by Celtic Pharma Holdings Advisors LLP, a Chief Financial Officer by Oxford GlycoSciences Plc, a Chairman by Ah Animal Healthcare Ltd., a Principal by Apax Partners LLP, a Principal by Barings Plc, a Head-Partner Network, Research & Development by Bedford Royalties Ltd., a Non-Executive Director by Gammadelta Therapeutics Ltd., a Consultant by PA Consulting Group Holdings Ltd., a Co-Founder by UK Stem Cell Foundation, and a Principal by Warburg Group Plc.
He also served on the board at Albucasis Ltd., Celtic Pharma Development UK Plc, Celtic Pharma GP Ltd., Houlihan Lokey Advisory Ltd., Novacta Biosystems Ltd., PBB Devices Ltd., Xenova Group Plc and Xenova Ltd. He received his undergraduate degree from the University of East Anglia, an MBA from Bayes Business School and a doctorate degree from the University of Oxford.

Participaciones conocidas en empresas públicas

EmpresaFechaNúmero de accionesValoraciónFecha de valoración
26/03/2025 405.045 ( 0,29 % ) 184 194 $ 31/08/2026
12/03/2026 0 ( -.--% ) - $ 31/08/2026

Cargos activos de Stephen Parker

EmpresasCargoInicio
BIODEXA PHARMACEUTICALS PLC Presidente 20/06/2022
SAREUM HOLDINGS PLC Presidente 17/05/2016
Sp2 Consulting Ltd.
Director/Miembro de la Junta -
Eternans Ltd.
Director/Miembro de la Junta 01/07/2019
Presidente 01/01/2021
Director/Miembro de la Junta -
Sp2 Asset Management Ltd.
Director/Miembro de la Junta 01/09/2018
Inversor de Capital Privado 01/04/2005

Antiguos cargos conocidos de Stephen Parker.

EmpresasCargoFin
ARGENT BIOPHARMA LIMITED Presidente 01/12/2023
░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░ ░░░░░░░░░ ░░░░ ░░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░ ░░ ░░░░░ ░░░░░░░░░░
Ver el detalle de la experiencia de Stephen Parker.

Formación de Stephen Parker.

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Relaciones

62

Relaciones de 1er grado

33

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Empresas relacionadas

Empresas privadas33

Commercial Services

Miscellaneous

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Commercial Services

Finance

Finance

Health Technology

Finance

Commercial Services

Consumer Services

Finance

Finance

Consumer Services

Miscellaneous

Health Technology

Finance

Health Technology

Retail Trade

Celtic Pharma GP Ltd.

Xenova Ltd.

Commercial Services

Health Technology

Health Technology

Sp2 Consulting Ltd.

Health Technology

Health Technology

Eternans Ltd.

Health Technology

Sp2 Asset Management Ltd.